BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36434160)

  • 1. Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases.
    Huynh C; Ryu J; Lee J; Inoki A; Inoki K
    Nat Rev Nephrol; 2023 Feb; 19(2):102-122. PubMed ID: 36434160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR signaling in renal ion transport.
    Adella A; de Baaij JHF
    Acta Physiol (Oxf); 2023 May; 238(1):e13960. PubMed ID: 36906912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
    Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD
    J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrient signaling to mTOR and cell growth.
    Jewell JL; Guan KL
    Trends Biochem Sci; 2013 May; 38(5):233-42. PubMed ID: 23465396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systems study reveals concurrent activation of AMPK and mTOR by amino acids.
    Dalle Pezze P; Ruf S; Sonntag AG; Langelaar-Makkinje M; Hall P; Heberle AM; Razquin Navas P; van Eunen K; Tölle RC; Schwarz JJ; Wiese H; Warscheid B; Deitersen J; Stork B; Fäßler E; Schäuble S; Hahn U; Horvatovich P; Shanley DP; Thedieck K
    Nat Commun; 2016 Nov; 7():13254. PubMed ID: 27869123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth or death? Control of cell destiny by mTOR and autophagy pathways.
    Khalil MI; Ali MM; Holail J; Houssein M
    Prog Biophys Mol Biol; 2023 Dec; 185():39-55. PubMed ID: 37944568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrient regulation of the mTOR complex 1 signaling pathway.
    Kim SG; Buel GR; Blenis J
    Mol Cells; 2013 Jun; 35(6):463-73. PubMed ID: 23694989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK and mTOR in cellular energy homeostasis and drug targets.
    Inoki K; Kim J; Guan KL
    Annu Rev Pharmacol Toxicol; 2012; 52():381-400. PubMed ID: 22017684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using
    Frappaolo A; Giansanti MG
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK--sensing energy while talking to other signaling pathways.
    Hardie DG
    Cell Metab; 2014 Dec; 20(6):939-52. PubMed ID: 25448702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic target of rapamycin: integrating growth factor and nutrient signaling in the collecting duct.
    Brown AL; Fluitt MB; Ecelbarger CM
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F413-F416. PubMed ID: 29846113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic mTOR: the rookie energy sensor.
    Martínez de Morentin PB; Martinez-Sanchez N; Roa J; Ferno J; Nogueiras R; Tena-Sempere M; Dieguez C; Lopez M
    Curr Mol Med; 2014 Jan; 14(1):3-21. PubMed ID: 24236459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase N controls a lysosomal lipid switch to facilitate nutrient signalling via mTORC1.
    Wallroth A; Koch PA; Marat AL; Krause E; Haucke V
    Nat Cell Biol; 2019 Sep; 21(9):1093-1101. PubMed ID: 31451768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling.
    Wang B; Jie Z; Joo D; Ordureau A; Liu P; Gan W; Guo J; Zhang J; North BJ; Dai X; Cheng X; Bian X; Zhang L; Harper JW; Sun SC; Wei W
    Nature; 2017 May; 545(7654):365-369. PubMed ID: 28489822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lysosome: a crucial hub for AMPK and mTORC1 signalling.
    Carroll B; Dunlop EA
    Biochem J; 2017 Apr; 474(9):1453-1466. PubMed ID: 28408430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR-dependent cell survival mechanisms.
    Hung CM; Garcia-Haro L; Sparks CA; Guertin DA
    Cold Spring Harb Perspect Biol; 2012 Dec; 4(12):. PubMed ID: 23124837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disentangling the signaling pathways of mTOR complexes, mTORC1 and mTORC2, as a therapeutic target in glioblastoma.
    Jhanwar-Uniyal M; Dominguez JF; Mohan AL; Tobias ME; Gandhi CD
    Adv Biol Regul; 2022 Jan; 83():100854. PubMed ID: 34996736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and metabolic functions of mTORC1 and mTORC2.
    Szwed A; Kim E; Jacinto E
    Physiol Rev; 2021 Jul; 101(3):1371-1426. PubMed ID: 33599151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR substrate phosphorylation in growth control.
    Battaglioni S; Benjamin D; Wälchli M; Maier T; Hall MN
    Cell; 2022 May; 185(11):1814-1836. PubMed ID: 35580586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.